{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:17:37Z","timestamp":1782256657487,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ccl.2013.09.015","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:46:44Z","timestamp":1385426804000},"page":"9-19","source":"Crossref","is-referenced-by-count":55,"title":["Pathophysiology and Etiology of Heart Failure"],"prefix":"10.1016","volume":"32","author":[{"given":"Frances L.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ccl.2013.09.015_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.015_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/07853890.2012.660493","article-title":"Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults","volume":"45","author":"Alagiakrishnan","year":"2013","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.ccl.2013.09.015_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.CIR.9.5.706","article-title":"Ventricular function: I. Starling's law of the heart studied by means of simultaneous right and left ventricular function curves in the dog","volume":"9","author":"Sarnoff","year":"1954","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2013.09.015_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.CIR.94.4.683","article-title":"Existence of the Frank-Starling mechanism in the failing human heart: investigations on the organ, tissue, and sarcomere levels","volume":"94","author":"Holubarsch","year":"1996","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2013.09.015_bib5","first-page":"e147","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation","volume":"62","author":"Yancy","year":"2013","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.ccl.2013.09.015_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ejechocard\/jer107","article-title":"Right ventricular quantification in clinical practice: two-dimensional vs. three-dimensional echocardiography compared with cardiac magnetic resonance imaging","volume":"12","author":"van der Zwaan","year":"2011","journal-title":"Eur J Echocardiogr"},{"issue":"5","key":"10.1016\/j.ccl.2013.09.015_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCULATIONAHA.108.811547","article-title":"Cardiovascular magnetic resonance","volume":"121","author":"Pennell","year":"2010","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ccl.2013.09.015_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccl.2013.09.015_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.015_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1388-9842(00)00096-9","article-title":"The role of cardiovascular magnetic resonance in heart failure","volume":"2","author":"Rajappan","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2013.09.015_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1532-429X-14-31","article-title":"Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance","volume":"14","author":"Reiter","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11886-011-0242-x","article-title":"Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT","volume":"14","author":"Arrighi","year":"2012","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"10.1016\/j.ccl.2013.09.015_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jcct.2008.05.144","article-title":"Assessment of cardiac volumes by multidetector computed tomography","volume":"2","author":"Lin","year":"2008","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"issue":"6","key":"10.1016\/j.ccl.2013.09.015_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12410-009-0052-3","article-title":"Value of cardiac CT in patients with heart failure","volume":"2","author":"Mangalat","year":"2009","journal-title":"Curr Cardiovasc Imaging Rep"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.015_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCIMAGING.108.822809","article-title":"Sixty-four-slice multidetector computed tomography: an accurate imaging modality for the evaluation of coronary arteries in dilated cardiomyopathy of unknown etiology","volume":"2","author":"Andreini","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ccl.2013.09.015_bib16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cardfail.2008.05.004","article-title":"High mortality without escape: the registry of heart failure patients receiving pulmonary artery catheters without randomization","volume":"14","author":"Allen","year":"2008","journal-title":"J\u00a0Card Fail"},{"issue":"8","key":"10.1016\/j.ccl.2013.09.015_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCHEARTFAILURE.111.965020","article-title":"Multiple biomarkers for risk prediction in chronic heart failure","volume":"5","author":"Ky","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(01)01744-2","article-title":"Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea","volume":"39","author":"Morrison","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2013.09.015_bib20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0735-1097(92)90243-G","article-title":"Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive failure, dilated cardiomyopathy and coronary artery disease","volume":"20","author":"Hare","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2013.09.015_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcmg.2008.05.009","article-title":"Chronic ischemic left ventricular dysfunction","volume":"1","author":"Rahimtoola","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2013.09.015_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-5273(02)00532-6","article-title":"Prognostic importance of the quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction","volume":"90","author":"Meluz\u0131\u0301n","year":"2003","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/euhj.1999.1663","article-title":"Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism","volume":"21","author":"Pasquet","year":"2000","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2013.09.015_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCULATIONAHA.109.903369","article-title":"Predicting benefit from revascularization in patients with ischemic heart failure: imaging of myocardial ischemia and viability","volume":"123","author":"Buckley","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2013.09.015_bib25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.015_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(98)00642-1","article-title":"Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability","volume":"33","author":"Marwick","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.015_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"Heart Failure"},{"issue":"1","key":"10.1016\/j.ccl.2013.09.015_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10741-010-9169-3","article-title":"Cellular and molecular pathways to myocardial necrosis and replacement fibrosis","volume":"16","author":"Gandhi","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ccl.2013.09.015_bib29","series-title":"Heart failure: a companion to Braunwald's heart disease","author":"Mann","year":"2010"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.015_bib30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cardiores.2005.10.004","article-title":"Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation","volume":"69","author":"Deschamps","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejheart.2007.12.002","article-title":"Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure","volume":"10","author":"Yan","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0008-6363(00)00003-1","article-title":"Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling","volume":"46","author":"Li","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"16","key":"10.1016\/j.ccl.2013.09.015_bib33","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","article-title":"Apoptosis in myocytes in end-stage heart failure","volume":"335","author":"Narula","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccl.2013.09.015_bib34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.RES.87.10.856","article-title":"Apoptosis during cardiovascular development","volume":"87","author":"Fisher","year":"2000","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.ccl.2013.09.015_bib35","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI29134","article-title":"TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways","volume":"117","author":"Haudek","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.ccl.2013.09.015_bib36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca2+ handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.ccl.2013.09.015_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/CRD.0b013e3182749cdb","article-title":"Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure","volume":"21","author":"Papolos","year":"2013","journal-title":"Cardiol Rev"},{"issue":"9","key":"10.1016\/j.ccl.2013.09.015_bib38","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCRESAHA.110.231902","article-title":"CaMKII inhibition in heart failure makes jump to human","volume":"107","author":"Bers","year":"2010","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.ccl.2013.09.015_bib39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ccl.2013.09.015_bib40","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2011.01.015","article-title":"Update 2011: clinical and genetic issues in familial dilated cardiomyopathy","volume":"57","author":"Hershberger","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.015_bib41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10897-012-9544-4","article-title":"Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families","volume":"22","author":"Miller","year":"2013","journal-title":"J\u00a0Genet Couns"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America practice guideline","volume":"15","author":"Hershberger","year":"2009","journal-title":"J\u00a0Card Fail"},{"issue":"6","key":"10.1016\/j.ccl.2013.09.015_bib44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/hrt.2005.073890","article-title":"Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications","volume":"92","author":"West","year":"2006","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ccl.2013.09.015_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cardfail.2010.04.005","article-title":"Executive summary: HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J\u00a0Card Fail"},{"issue":"9","key":"10.1016\/j.ccl.2013.09.015_bib46","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/eurjhf\/hft090","article-title":"Computed tomography coronary imaging as a gatekeeper for invasive coronary angiography in patients with newly diagnosed heart failure of unknown aetiology","volume":"15","author":"Ten Kate","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.ccl.2013.09.015_bib47","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/CIRCULATIONAHA.110.011346","article-title":"Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology","volume":"124","author":"Assomull","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ccl.2013.09.015_bib48","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jacc.2010.05.014","article-title":"Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis","volume":"56","author":"Chen","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2013.09.015_bib49","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.108.191650","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2013.09.015_bib50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcmg.2009.11.017","article-title":"Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting?","volume":"3","author":"Laskey","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.015_bib51","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2013.09.015_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/heart.83.1.81","article-title":"Clinical significance of the bicuspid aortic valve","volume":"83","author":"Ward","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2013.09.015_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-022811-091602","article-title":"Mitral valve prolapse","volume":"63","author":"Guy","year":"2012","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.015_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCRESAHA.111.300084","article-title":"Current management of calcific aortic stenosis","volume":"113","author":"Lindman","year":"2013","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.015_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.108.817346","article-title":"Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Hershberger","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.ccl.2013.09.015_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/CIRCRESAHA.110.224592","article-title":"Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins","volume":"107","author":"Ackerman","year":"2010","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.ccl.2013.09.015_bib57","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","article-title":"Viral persistence in the myocardium is associated with progressive cardiac dysfunction","volume":"112","author":"K\u00fchl","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2013.09.015_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","article-title":"Myocarditis","volume":"52","author":"Blauwet","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"issue":"33","key":"10.1016\/j.ccl.2013.09.015_bib59","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccl.2013.09.015_bib60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.0000048147.15962.31","article-title":"Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders","volume":"107","author":"Frustaci","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccl.2013.09.015_bib61","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","article-title":"Usefulness of immunosuppression for giant cell myocarditis","volume":"102","author":"Cooper","year":"2008","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.ccl.2013.09.015_bib62","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2013.09.015_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2013.02.007","article-title":"State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review","volume":"88","author":"Berardi","year":"2013","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865113000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865113000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T14:54:55Z","timestamp":1539010495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865113000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0733865113000982"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2013.09.015","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}